AI Article Synopsis
- The study highlights that the rate of cryptococcosis in HIV-negative individuals in the U.S. is becoming similar to that in HIV-positive patients.
- Cryptococcosis is a serious fungal infection that is increasingly affecting those without HIV, including people who have received organ transplants.
- Mortality rates for cryptococcosis are notably higher in HIV-negative patients compared to their HIV-positive counterparts.
Article Abstract
In this population-based study in the contemporary era in the United States, the proportion of human immunodeficiency virus (HIV)-negative patients with cryptococcosis approaches that in HIV-infected patients. Cryptococcosis is associated with higher mortality rates in HIV-negative patients (including organ transplant recipients).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849089 | PMC |
| http://dx.doi.org/10.1093/cid/cix867 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Public Health.
Alzheimers Dement
December 2024
Boramae Medical Center, Seoul, Dongjak, Korea, Republic of (South).
Background: Cognitive decline often follows human immunodeficiency virus (HIV) infection, yet the specific risk factors for developing Alzheimer's disease and related dementia (ADRD) in HIV patients remain elusive.
Method: To investigate the association between acquired immune deficiency syndrome (AIDS) status at the time of HIV diagnosis and the risk of ADRD, we conducted a retrospective cohort study using data from a nationwide claim database spanning 2008 to 2021. During the study period, 13,289 patients were newly diagnosed with HIV infection and were prescribed antiretroviral therapy (ART).
Public Health.
Alzheimers Dement
December 2024
King's College London, Strand, London, United Kingdom.
Background: The prevalence of dementia in low- and middle-income countries is increasing, yet epidemiological data from African populations remains scarce. Crucial risk factors differ in Africa from more intensively studied global areas, including a high burden of cerebrovascular disease (evidenced by high stroke incidence) and HIV, but lower rates of other risk factors such as physical inactivity. In the pre-antiretroviral therapy era, dementia was a common consequence of HIV infection.
View Article and Find Full Text PDFBackground: Once an incurable deadly disease of urgent public health concern, human immunodeficiency virus (HIV) infection has now evolved into a chronic condition largely manageable with combination therapy as the treatment standard. In comparison, Alzheimer disease (AD) is a fatal illness that continues to pose epidemiologic and socioeconomic challenges not only to persons and families affected by it but also to the healthcare system as a whole. With the recent approval of multi-targeted therapies in AD and numerous clinical trials in the pipeline, there is an urgency to search for ways to best maximize their efficacy and utility.
View Article and Find Full Text PDFBackground: Malawians, in Sub-Saharan Africa (SSA), face the double burden of HIV and Alzheimer's disease and related dementia (ADRD). The life expectancy among HIV-positive people on antiretroviral therapy has increased consistently over the past 25 years. The purpose of the study was to determine the prevalence of dementia among people living with HIV (PLWHIV) and the general population without HIV as a comparison group in Malawi.
View Article and Find Full Text PDFBackground: Individual plasma protein biomarkers have been shown to correlate with cognitive performance in people with HIV. This study aimed to investigate the association between plasma proteomic signatures and cognition in virologically well-controlled women with HIV.
Method: 77 women with HIV from three Women's Interagency Study (WIHS) sites completed neuropsychological testing and a blood draw.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!